Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05908240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05908240 · ClinicalTrials.gov record · last posted 2026-08-06

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Study acronym: CP3
StatusActive, Not Recruiting
PhaseNot applicable
Started2023-06-15
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Protocol amendment history 3 changes detected by DataLookout

2026-08-07
Primary completion pushed: 2026-06 → 2026-09
2026-08-07
Completion pushed: 2026-07 → 2026-10
2026-06-02
Trial sites expanded: 10 → 20 locations
Trial Details
NCT Number NCT05908240
Lead Sponsor University of Pennsylvania
Collaborators: National Psoriasis Foundation
Conditions Psoriasis, Psoriatic Arthritis, Psoriatic Conditions, Cardiovascular Diseases
Enrollment 520 participants
Start Date 2023-06-15
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-06